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INTRODUCTION 
Diabetes mellitus is a ubiquitous disease with an ancient history.  
It is common, being present in approximately 3% of adult population.  
Diabetes is an important cause of blindness in people of working age.  
Although we often think of retinal changes, it must not be forgotten that 
other parts of the visual system are affected in diabetics.  Diabetes 
increases the possibility of cataract and is the next common cause 
blindness after diabetic retinopathy.  Cataract is a common complication 
of diabetes indeed it has been estimated that upto 15% of cataract 
surgery is performed  on diabetics. 
The global prevalence of type 2 DM is expected to double in the 
period 2000 – 2025 and may reach a level of 300 million people. In 
India the urbanization factor, producing lifestyle changes that adversely 
affect metabolism is causing a large increase in the number of diabetic 
patients14,38.  Diabetes occurs at the younger age (45-64 years) 
prevalence in urban Indian adults was increased from 5.2% in 1984 to 
13.9% in 2000.  The prevalence in Chennai was 11.6%.  There are 
approximately 33 million adults with diabetes in India and it likely to 
increase to 57.2 million by the year 2025.  The number of diabetics is on 
the rise and eventually diabetic cataract. 
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AIMS AND OBJECTIVES 
 
The aim of the study is to find the incidence of cataract with 
regard to age, sex, the complications of the cataract surgery,  
(Per-operative and post-operative) and visual outcome after surgery in a 
diabetic population. 
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REVIEW OF LITERATURE 
 
Diabetes mellitus - an overview 
 Diabetes Mellitus is defined as a group of metabolic diseases 
characterized by hyperglycemia resulting from defects in insulin 
secretion, insulin action, or both. The American Diabetes Association 
Expert Panel recommends a diagnosis of diabetes mellitus when one of 
the three criteria is met.  
 
Criteria for the diagnosis of Diabetes Mellitus 
1) Symptoms of diabetes plus casual plasma glucose concentration  
≥ 200 mg/dl. 
Casual is defined as anytime of day without regard to time since last 
meal. The classic symptoms of diabetes include polyuria, poly dipsia 
and unexplained weight loss. 
2) Fasting plasma glucose ≥ 126 mg/dl. Fasting is defined as no caloric 
intake for at least 8 hours. 
3) 2 hours plasma glucose ≥ 200 mg/dl during an oral glucose tolerance 
test.  
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DIABETES MELLITUS CLASSIFICATION 
The new classification identifies four types of diabetes mellitus36.  
Type 1, Type 2, “Other specific types” and gestational diabetes.  
Type 1 : (Formerly IDDM / Juvenile onset DM) is characterized by  
β-cell destruction due to autoimmune process leading to absolute insulin 
deficiency. 
Type 2 : (NIDDM / Adult onset) is characterized by insulin resistance in 
peripheral tissues and an insulin secretary defect of the β cells. 
Other Specific Types : includes persons with genetic defects of β cell 
function (MODY or Maturity onset Diabetes Mellitus) or with defects of 
insulin action.  Persons with diseases of exocrine pancreas, dysfunction 
associated with endocrinopathies. 
Gestational Diabetes Mellitus 
PATHOGENIC MECHANISMS IN DIABETIC EYE DISEASE 
1) Protein glycosylation 
2) Aldose reductase activity 
3) Glycosylated hemoglobin  
↓  
Relative tissue hypoxia → final common pathway 
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I. PROTEIN GLYCOSYLATION : 
 A nonenzymatic reaction of glucose with lysine residue of 
proteins. A high level of serum glucose is necessary to produce this type 
of protein glycosylation. The resulting chemical compound rearranges 
and is transformed into an irreversible structure called ‘Amadori’ 
product. Proteins and Amadori product form ‘Advanced glycosylation 
end products’ which causes release of biologically active molecules that 
cause microvascular changes similar to diabetic retinopathy.  
II. ALDOSE REDUCTASE ACTIVITY 
 In the presence of high concentration of sugars, aldose reductase 
enzyme converts sugars to alcohols. Pericytes and endothelial cells of 
retinal vasculature have high concentration of this enzymes. Therefore 
an increase in blood glucose leads to an increase in alcohols in the 
pericytes and endothelial cells, which in turn cause death of these cells. 
Aldose reductase enzyme and its cellular after effects have been 
implicated in ocular problems associated with Diabetes mellitus. 
III. GLYCOSYLATED HAEMOGLOBIN : 
 High blood glucose leads to increase in glycosylated 
haemoglobin. Release of oxygen from glycosylated Hb is slow and 
difficult compared to non-glycosylated Hb. This leads to a relative tissue 
hypoxia. Glycosylated Hb stimulates VEGF release.  
  
6 
 
 Glycosylated Hb ≤ 7 prevents the development of diabetic 
retinopathy or slows the progression. 
Anatomy and physiology of the lens 
 The crystalline lens is a transparent, biconvex structure whose 
functions are to  
• Maintain its own clarity 
• Refract light 
• Provide accommodation 
There is lack of blood supply and innervation to the lens and it 
depends entirely on the aqueous humor for its metabolic requirements. 
The lens is suspended by the zonules of zinn and lies posterior to the iris 
and anterior to the vitreous body. Refractive Index is 1.4 in the center 
and 1.36 peripherally. The lens contributes about 15-20 diopter of the 
refractive power of the eye. 
The anterior and posterior poles of the lens are joined by an 
imaginary line called the axis. The greatest circumference of the lens is 
the equator. The crystalline lens grows throughout human life and 
weight about 255 mg in an adult. The lens capsule is an elastic, 
transparent basement membrane made of Type IV collagen. The zonular 
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lamella, which is the outer layer, gives attachment to the zonular fibers. 
The lens capsule is thickest in the anterior and posterior preequatorial 
zones and thinnest in the region of the central posterior pole. The 
zonules arising from the basal laminae of the NPE of the pars plana and 
pars plicata of the ciliary body support the lens. They insert on the lens 
capsule in the equatorial region.  
Epithelium: 
 A single layer of epithelial cells are seen behind the anterior 
capsule. Epithelium is the most metabolically active structure in the 
lens. Its activities include synthesis of DNA, RNA, Protein, lipid and 
ATP generation. The epithelial cells in S-phase occur in a ring around 
the anterior lens, the germinative zone. These newly formed cells 
migrate towards the equator, where they differentiate into fibers. The 
epithelial cells migrate toward the low region of the lens, where the 
process of terminal differentiation into lens fibers takes place. While the 
epithelial cells elongate to form lens fibers, there is a tremendous 
increase in cellular proteins, loss of organelles (nuclei, mitochondria and 
ribosomes) and becomes dependent on glycolysis for energy. 
Nucleus & cortex: 
 The oldest fibers are the central most, as the new fibers laid 
down, crowd and compact the previously formed fibers. Embryonic and 
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fetal nuclei persist in the center of the lens. Recently formed fibers make 
up the cortex. Anterior and posterior sutures are due to the 
interdigitations of the apical cell process and basal cell processes 
respectively. 
Lens physiology and biophysics 
 Mechanisms that control the water and electrolyte balance which 
is most important in maintaining the transparency of the lens, forms the 
basic physiology. 66% Water and 33% Protein. i.e. (Cortex is more 
hydrated) 
 The lens epithelium is the metabolically most active site. The 
levels Na+ and Cl– ions are lower and K+ ions are higher in the lens 
compared to the external milieu. The ionic balance is maintained by the 
Na+-K+-ATpase pump located in the cell membranes of the lens 
epithelium and each lens fiber. 
Pump -leak theory   
 Active transport and membrane permeability together is often 
referred as the pump-leak system of the lens. According to the pump-
leak theory potassium, amino acids and various other molecules are 
transported into the anterior lens through the epithelium. An 
anteroposterior ionic gradient occurs according to this theory. Potassium 
is more in the anterior fibers and sodium in the posterior cortex. Na+, 
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K+-ATpase activity is greatest in the epithelium. Two K+ ions are 
pumped into the cell as three Na+ ions are pumped out. 
Amino acid & sugar transport: 
 Most of the amino acids are transported into the lens from the 
aqueous against a concentration gradient as part of the pump leak 
concept. Three different pumps one each for acidic, basic and neutral 
amino acids have been reported. 
 Glucose            Simple diffusion 
           →  + 
 Transport           facilitated diffusion 
Calcium homeostasis is through a Ca2+–ATpase pump which 
maintains a large transmembrane calcium gradient. Intracellular pH of 
lens = 7. 
Electrophysiology: 
 Resting Membrane potential  = –50mv at 20 yrs 
      = –20mv at 80 yrs 
Lens transparency: 
The crystalline lens is transparent because of  
• Absence of chromophores in young lens that absorbs visible light. 
• Highly organized regular lamellar conformation of the lens proteins, 
that causes minimal light scatter. 
• Absence of organelles in the mature lens fibers. 
  
10 
• Less fibers form a hexagonal lattice and the amount of intracellular 
space is small.  
• The difference in Refractive index between different structures of the 
lens is negligible.  
Light transmittance: 
 The lens absorbs 
• UV – B → 300 – 315 nm 
• UV – A → 315 – 400 nm and also absorbs infrared radiation. 
 The transmittance of young lens begins at about 310nm and 
reaches 90% at 450nm, compared with older lens > 60 years, begins 
transmitting at 400nm but does not reach 90% total transmittance until 
540nm. 
Refractive indices: 
• Peripheral cortex → refractive index = 1.386 
• Nucleus → refractive index = 1.41 
Accommodation: 
 The mechanism by which the eye changes focus from distant to 
near images, is produced by a change in lens shape resulting from action 
of the ciliary muscle on the zonular fibers.  
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BIOCHEMISTRY OF THE LENS 
Lens proteins: 
 Proteins in lens accounts for 33% of its wet weight, which is 
twice that of other tissues. Intracellular proteins are of two types, water 
soluble and water insoluble. Water soluble are α crystallins and β  
crystallins 
α Crystallins:   
• 32% of lens protein 
• Largest → 600 – 800 KD molecular weight  
• Specifically involved in the transformation 
• Of epithelial cells into lens fibers. 
β  Crystallins: 
• 55% of water soluble proteins of lens 
• complex group of oligomers composed of polypeptides from 23-
32KD  
γ Crystallins:  
• Monomeric proteins with molecular mass 20 KD 
• Concentrated in the nucleus 
•  γ Crystalline →  adult lens cortex 
• Taxon specific crystallins are also present. 
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Cytoskeletal and membrane proteins: 
The water insoluble proteins form the major cytoskeletal and 
membrane elements. They include actin, vimentin, tubulin, filensin and 
phakinia. Major intrinsic protein (MIP) form 50% of the membrane 
protein. 
Post translational modifications: 
 The lens proteins are the longest links in the human body. These 
proteins become structurally modified in a variety of ways → oxidation 
of sulphur and aromatic residue side chains, polypeptide, cross-links, 
glycosylation, racemization etc. 
Glucose metabolism of the lens: 
 Glucose metabolism is the main source of energy. 
Utilization of Glucose is by 
• 80% - Glycolytic pathway 
• 10% - HMP shunt 
• 5% - Sorbitol Pathway 
• 5% - Gluconic acid 
Due to its avascularity and location in the ocular humors, the lens 
exists in a hypoxic environment. 70% of lens ATP is derived from 
anaerobic glycolysis. 3% per molecule of glucose passes into the Kreb’s 
cycle, which generates 25% of lens ATP. Metabolism of one molecule 
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of glucose by anaerobic glycolysis yields only 2 molecules of ATP 
where as 36 molecules are produced in aerobic glycolysis. HMP shunt 
utilizes glucose 6 phosphate and produces NADPH and pentose. 
NADPH is needed to maintain lens glutathione in reduced state and in 
sorbitol pathway. 
Protein metabolism: 
 Proteins are synthesized from the free amino acids that are 
transported from the aqueous occurs only in the epithelial cells and 
surface cortical fibers. 
Antioxidant mechanisms: 
 Reactive oxygen species can easily damage lipids, proteins, 
carbohydrates and nucleic acids. Such radicals include super oxide 
anion, hydroxyl free radical, hydroperoxyl radicals, lipid peroxyl 
radicals etc. Protection against such damage is by antioxidants like super 
oxide dismutase, ascorbate, catalase or glutathione peroxidase. 
CATARACT FORMATION IN DIABETES  
Pathogenesis: 
(i) Sorbitol pathway and osmotic hypothesis : 
Aldose reductase is the key enzyme in the pathway that converts 
sugars into the corresponding sugar alcohols. Aldose reductase has a 
very high Km for glucose / galactose. Under normal condition little or 
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no activity occurs through this pathway. In hyperglycemic state, aldose 
reductase competes with hexokinase for glucose. 
 
Glucose  Galactose 
NADPH  NADPH 
                  Aldose Reductase 
NADP+  NADP+ 
Sorbitol  Dulcitol 
NAD+  NAD+ 
                   Polyol Dehydrogenase 
NADH  No Reaction 
Fructose   
 
This leads to an increase in intracellular sorbitol. It is unable to 
penetrate cell membranes and trapped inside the cells. Under conditions 
of hyperglycemia, this creates an osmotic pressure that draws water into 
the lens. The levels of polyol dehydrogenase are much higher in human 
lenses compared to aldose reductase. 
   
Swelling of cells 
↓ 
Damage to membranes 
↓ 
Formation Foci of interfibrillar and intracytoplasmic light scattering 
↓ 
Cataract Formation 
Non -enzymatic glycosylation: 
 Non-enzymatic glycation of proteins by the Maillard reaction 
results in the formation of advanced glycation end products that induce 
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cataract formation. There is a conformational alteration progressing to 
thiold oxidation, aggregation, formation of disulphide and other covalent 
cross links and inactivation of enzymes. 
Other mechanisms suggested 
o carbamylation of crystallins 
o Auto oxidation of sugars. 
Lens changes in diabetes: 
 Diabetics have lenses that are larger than normal for age. The 
lenses of an adult diabetic are said to be in the same condition as the 
lenses of a non-diabetic who is 15 years older. The refractive index of 
the lens is altered due to increased hydration. Patients with diabetes 
show transient refractive changes due to changes in their blood sugars. 
Acute myopic shifts may indicate undiagnosed or poorly controlled 
diabetes. Changes in the hydration of the lens and glycogen deposits in 
the ciliary body decrease the ciliary body’s ability to function. This 
leads to a decreased amplitude and presbyopia may present at an earlier 
age in patients with diabetes than in non-diabetics. 
MORPHOLOGY OF DIABETIC CATARACT:  
I. Snowflake or true diabetic cataract: 
- < 30 yrs age, bilateral, uncontrolled D.M. 
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- widespread sub capsular changes of abrupt onset and acute 
progression. 
- Multiple gray white sub capsular opacities that have a snowflake 
appearance, seen initially in the superficial anterior and posterior 
lens cortex.  
- Total opacification can occur over a period of few weeks. 
II. Polychromatic type: 
- Fine needle – shaped polychromatic cortical opacities may also 
form. 
III. Senescent cataract: 
- Frequently observed in diabetes. The Health and Nutrition 
examination survey and the Framingham eye study found an 
incidence of typical senile cataracts to be increased by a factor of 
3 or more in diabetic individuals compared with age matched 
non-diabetics. Lens changes tend to occur at a younger age than 
in patients without diabetes. 
1. Cortical cataracts 
- Bilateral but often asymmetric 
- Vary in rate of progression 
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- The first sign is visible with slit lamp biomicroscope – vacuoles 
and water clefts in the anterior or posterior cortex. Cortical 
lamellae may be separated by fluid. 
- Wedge – shaped opacities (cortical spokes / cuneiform opacities) 
form near the periphery of the lens, with the pointed end of the 
opacities oriented towards the center. It appears as white 
opacities when viewed with slit lamp and as dark shadows when 
viewed by retro illumination. 
- As the lens continues to take up water it may swell and become 
an Intumescent cortical cataract. 
- The entire cortex from the capsule to the nucleus becomes white 
and opaque, to form a mature cataract. 
- Hypermature cataract occurs when degenerated cortical material 
leaks through the lens capsule, leaving the capsule wrinkled and 
shrunken. 
- Morgagnian cataract occurs due to liquefaction of the cortex 
allows free movement of the nucleus within the capsular bag. 
2. Posterior sub capsular cataract: 
- PSCC  are located in the posterior cortical layer and usually axial. 
- The first indication of PSC formation is a subtle iridescent sheen 
in posterior cortical layers. 
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- Often seen in younger patients 
- HPE shown posterior migration of lens epithelial cells in PSC 
area with aberrant enlargement. The swollen epithelial cells are 
called wedl or bladder cells. (Dysplastic changes in germinal 
epithelium) 
3. Nuclear cataract: 
- An excessive amount of sclerosis and yellowing is called 
Nuclear Cataract that causes a central opacity. 
- Rate of progression is slow. 
- Advanced cases, lens nucleus becomes opaque and brown and are 
called a brunescent nuclear cataract. 
 
SYMPTOMS AND SIGNS OF DIABETIC CATARACT 
  
1) Decreased visual acuity : 
The patient often tells that he has visual impairment. Different 
types of cataract have different effects on visual acuity, rapid onset of 
decreased vision occurs in true diabetic cataract. 
2) Myopic shift : 
The development of nuclear sclerosis leads to an increase in the 
dioptric power of the lens that causes myopia. Hyperopic presbyopic 
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patients find their need for distances glasses diminished and this is 
called second sight 
3) Glare : 
Patients complain of increased glare sensitivity, which may vary 
from a decrease in contrast sensitivity in bright environment to disabling 
glare when looking at car headlights at night. 
4) Contrast sensitivity : 
It may demonstrate a significant loss of visual function not 
appreciated with snellen testing. However it is not a specific indicator of 
visual loss due to cataract.  
5)  Monocular Diplopia / Polyopia : 
 Sometimes nuclear changes are localized to the inner layers of 
the lens nucleus, resulting in multiple refractile areas in the center of the 
lens. This results in monocular diplopia, including a ghost images and 
occasionally a true second image. 
EFFECT OF CATARACT ON VISUAL ACUITY 
 
Type of 
cataract 
Growth 
Rate Glare 
Effect on 
distance 
Effect on 
near 
Induced 
myopia 
Cortical 2+ 1+ 1+ 1+ None 
Nuclear 1+ 1+ 2+ None 2+ 
Posterior sub 
capsular 
3+ 3+ 1+ 3+ None 
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INDICATIONS  FOR CATARACT SURGERY 
1) Patient’s desire for improved visual function : It is not based on a 
specific level of visual acuity. Both the patient and ophthalmologist 
determine if reduced visual function interferes substantially with 
desired activities.  ADVS (Activities of Daily Visional Scale) may be 
used. 
2) Loss of stereopsis, diminished peripheral vision, disabling glare or 
symptomatic anisometropia are indications for surgery in monocular 
cataract. 
3) Medical indications: 
a. Phacolytic glaucoma 
b. Phacomorphic glaucoma, 
c. Phacoantigenic uveitis 
d. Dislocation of lens into the anterior chamber. 
For diagnosis or management of diabetic retinopathy or other 
ocular diseases when a dense cataract obscures the fundus view. 
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PRE OPERATIVE EVALUATION IN DIABETICS 
GENERAL HEALTH  
There is an association with other systemic diseases like 
Ischaemic heart disease, systemic hypertension, obesity and diabetes.  
All medical problems especially prodiabetic states, should be evaluated  
and treteated appropriately.  Drug sensitivity and allergies should be 
documented.  Musculo skeletal disorders that limit the ability to lie 
comfortably, body habitus and head tremor should be taken care.   
GLYCEMIC CONTROL 
The stress of surgery exacerbates  the metabolic abnormalities.  
So meticulous attention to plasma glucose control is necessary.  The 
goal of treatment is to prevent hypoglycemia and ketoacidosis, by 
keeping  the plasma glucose levels between 150 – 250mg/dL and to 
maintain fluid and electrolyte balance.  If plasma glucose exceed 
300mg/dL additional regular insulin is given and rate of glucose 
infusion is increased  if plasma glucose is less than 150mg/dL.  Patients 
treated with diet may require small doses of regular insulin if blood 
sugar exceeds 300mg / dL.   
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Patients treated with sulphonyl ureas, the drug should be omitted 
on the day of surgery.  Insulin may be added, with respect to the plasma 
glucose levels.  In insulin dependent patients undergoing cataract 
surgery, the morning insulin dose may be delayed until the procedure is 
completed and the patient is fed.  HbA1c gives the exact status regarding 
glycemic control in the recent past.   
OCULAR EVALUATION : 
Diabetic patients are more prone to develop infective conditions 
of the ocular adnexa.  Blepharitis, as manifested by collarettes, marginal 
eye lid thickening, inspissation of meibomian gland secretions should be 
diagnosed and treated. 
Tear film abnormalities are to be assessed, as it has been reported 
that there is a decreased secretion and less uniform lipid layer and 
reduced tear breakup time which can delay post-operative recovery.  
Diabetic cornea is more prone to develop keratoepitheliopathy such as 
superficial punctate keratitis, recurrent corneal erosion, persistent 
epithelial defects and damage to corneal endothelium34.  Cataract 
surgery can place undue stress on the cornea and lead to 
keratoepitheliopathy13.  Motility of extra ocular muscles and ocular 
alignment should be evaluated.  Diabetic patients should be evaluated 
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for cranial nerve palsies as  diabetes is the most common cause of an 
acquired 6th and 3rd nerve palsy and second most common cause after 
trauma in acquired fourth nerve palsy. 
Evaluation of pupillary responses should be done.  RAPD should 
be looked for as diabetic papillopathy can occur in Type 1 diabetes in 
the 2nd or 3rd decades of life.  As a part of  The Blue Mountains Eye 
Study, it was indicated that there was a real association between a 
POAG and diabetes.  Ocular hypertension was more in diabetic patients.  
Proliferative disease may present as rubeosis iridis in the anterior 
segment.  Diabetes is the major cause of neovascular glaucoma.  Iris is 
examined to detect any neovascularisation, presence of synechiae, signs 
of uveitis and pseudo exfoliation syndrome should be noted and treated 
accordingly. Pre-operative goniosocpy  should rule out angle 
abnormalities PAS and neovascularisation.   
Appearance of the lens in slit lamp clarity of the media in the 
visual axis should be evaluated to assess the lenticular contribution to 
the visual deficit.  The integrity of the zonules and position of the lens  
must be evaluated. 
Patency of the nasolacrimal duct is important in avoiding 
complications due to infection. 
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Pre-operative refraction is useful in planning the IOL power 
necessary to obtain the postoperative refraction desired by the patients.   
A-Scan biometry is used to calculate the appropriate IOL power. 
Fundus examination to detect the status of the retina and staging 
of diabetic retinopathy is a prime importance before planning for 
cataract extraction. Visual acuity testing, brightness acuity, contrast 
sensitivity and test for macular function are done. 
Fundus examination if not possible due to an opaque media, B-
Scan USG of the posterior pole of the eye is useful.   
TIMING OF CATARACT SURGERY IN DIABETIC 
RETINOPATHY 50 
Visual 
symptoms due 
to cataract 
Diabetic retinopathy 
status 
Recommendation 
None None to moderate 
NPDR 
No surgery 
None Severe NPDR or PDR PRP 
None Diabetic maculopathy Macular laser 
Yes None to moderate 
NPDR  
Cataract surgery as soon as 
possible 
Yes Severe NPDR or PDR 
with good retinal view 
PRP first then cataract 
surgery after 4 months 
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Yes Severe NPDR or PDR 
with poor retinal view. 
Cataract surgery as soon as 
possible followed by 
perioperative indirect PRP 
on table in PDR and within 
three months in severe 
NPDR. 
Yes Diabetic maculopathy 
with good retinal view 
Macular laser first then 
cataract surgery after 6 
months 
Yes Diabetic maculopathy 
with poor retinal view 
Cataract surgery as soon as 
possible and treat pre-
existing diabetic 
maculopathy with macular 
laser as soon as possible 
(usually can be done within 
4 weeks) ; macular edema 
that develops 
postoperatively can often 
resolve spontaneously and 
can be observed for 6 
months before treatment.  
PATIENT PREPARATION : 
Mydriasis : The use of phenylephrine 10% and cyclopentolate 
2% produces effective mydriasis, multiple doses administered over one 
hour.  Pre-operative NSAIDS flurbiprofen  0.03% or suprofen 1% 
mitigates any intra-operative pupillary constriction.  Preservative free 
epinephrine 1:10,000 may be injected in to the AC at the start of 
surgery. 
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High molecular weight viscoelastic substance can increase  
mydriasis by applying direct mechanical pressure on pupillary margin 
during installation.  Healon 5 produces stable mydriasis2. 
PREVENTION OF INFECTION. 
¾ Incidence of infection  rate in cataract surgery is 0.072%. 
¾ Treatment of preexisting lid and lacrimal disease 
¾ Use of plastic adhesive drapes 
¾ 2 drops of povidone iodine 5% in the conjunctival sac for 1-2 
minutes, decreases the incidence of endophthalmitis significantly. 
¾ Lids and lashes prepared separately with cotton tipped swabs soaked 
in 5-10% providon iodine. 
¾ Care should be taken to drape the lashes out of the operative field 
and to minimize the time the eye is open.  The pre-operative use of 
antibiotics is controversial and the administration varies. 
¾ Systemic infections should be identified and treated prior to elective 
surgery.  Oral fluroquinolones are indicated in immunocompromised 
patients. 
ANAESTHESIA IN DIABETIC PATIENTS 
J.P. Barker, P.N. Robinsmith et al35 studied 40 elderly patients 
undergoing cataract surgery.  10 NIDDM received GA, 10 NIDDM 
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received LA.  10 non-diabetic controls received GA and the other 10 
non-diabetic controls received GA.   
The results showed that in both general anaesthesia groups, 
NIDDM and control, blood glucose and serum cortical concentration 
increased significantly during surgery before return to normal by 4 hours 
after operation.  In both local anaesthesia groups blood glucose and 
cortisol concentration change to return during surgery.  Serum insulin 
concentrations increased 30 minutes after surgery to coincide with the 
peak of the glucose increased in non-diabetics who received GA, but no 
insulin response was seen in the diabetic GA patients. The results 
showed that cataract surgery under local anaesthesia provides improved 
metabolic control for diabetic patient.  Its use maintains glucose 
homeostasis, prevents the increase in cortisol and glucose which are 
seen under GA and obviates the need for post operative starvation.   
TYPE OF CATRACT SURGERY AND INTRA OPERATIVE 
PRECAUTIONS  IN DIABETES  
The usage of heparinized infusion (concentration 10 IU /ml) in 
the irrigation solution, as result of anti-inflammatory and 
antiproliferative effects of heparin, may be beneficial in diabetic 
patients; however no real long term benefit was proven and most 
surgeons do not use it routinely.  This reduction in immediate and early 
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postoperative inflammation could benefit diabetic patients who are at 
risk for greater early postoperative inflammation.  Phacoemulsification 
is associated with better postoperative visual acuity,  less postoperative 
inflammation, and less need for capsulotomy than extracapsular cataract 
surgery in patients with diabetes, as shown previous studies.  Surgically 
induced miosis was found to have occurred more often in the diabetics 
and cataracts in type 2 diabetics were found to be sticky and leathery; 
therefore, it is advisable that phacoemulsification in this group of 
patients is undertaken by an experienced surgeon.  The surgeon’s skills 
affect surgery time, decrease the chance of intraoperative complications, 
and this lessen postsurgery inflammation, perhaps reducing the risk of 
retinopathy progression. 
Anterior capsular phimosis (or capsular contraction syndrome) is 
more common in diabetic patients37; therefore, the capsulorhexsis size 
should be larger than normal but smaller than the optic size of the IOL 
to prevent posterior capsular thickening.  Other studies have shown that 
combined phacoemulsification, insertion of a posterior chamber IOL, 
posterior capsulectomy, and pars plana vitrectomy can be used to treat 
patients with complications resulting from proliferative diabetic 
retinopathy and macular edema.  The combined suegery may prevent a 
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second operation for postvitrectomy cataract, allowing earlier visual 
rehabilitation.  Minimum invasion and avoiding excess contact with iris 
decreases the chance of post-operative inflammation and bleeding.   
IOL IN DIABETICS50 
Large diameter IOLs are still required to facilitate the 
visualization and pan retinal photocoagulation treatment of the 
peripheral retina. A 6.5-mm IOL, for example, provides a 39.7% larger 
optic area than a 5.5-mm IOL and could be crucial to adequate diabetic 
retinopathy management. Posterior capsule opacification is linked to the 
shape of the optic, such that a square-edged design inhibits lens 
epithelial cell proliferation. The hydrophobic acrylic lenses with square 
edges demonstrated similar low incidence of posterior capsule 
opacification in comparison to blunt-edged lenses. A silicone IOL 
causes poor visualization during vitreo-retinal procedures and should be 
avoided in patients at high risk of developing advanced diabetic 
retinopathy. Hydrophilic acrylic lenses have the lowest rate of silicone 
oil adherence and would be the IOL of choice in these high-risk patients. 
However, it should be noted that there have been some reports of 
progressive dystrophic calcific opacification of hydrophilic acrylic IOLs 
in diabetic patients and longer follow-up of these patients is indicated by 
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surgeons. The use of multifocal and accommodative IOLs in diabetics is 
controversial. 
SURGICAL RISK IN DIABETICS 
Surgical correction of diabetic cataract is also more problematic 
in these patients than their nondiabetic counterparts. Intuitively, 
exposing a pathologically compromised eye to surgical trauma and the 
resultant inflammatory mediator induction and neutrophil and 
macrophage recruitment is of concern. Evidence implicates the blood 
ocular barriers as crucial factors in the progression of diabetic 
retinopathy. Abnormalities in blood-retinal barrier function have been 
demonstrated in diabetics without demonstrable clinical retinopathy. 
The degree of blood-retinal barrier dysfunction increases as the level of 
diabetic retinopathy deteriorates as does the degree of blood-aqueous 
barrier dysfunction. 
           Numerous studies have been published that have sought to 
answer whether there is true progression in diabetic retinopathy, 
including maculopathy following uncomplicated cataract surgery. The 
ETDRS report #25 looked at cataract surgery in diabetes. A trend 
toward post surgical progression did not, however reach a pre 
determined level of statistical  significance (p = 0.01).  Also cataract 
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surgery did not appear to yield any significant long term risk of macular 
oedema18.  Uncomplicated phacoemulsification cataract surgery does 
not cause acceleration of diabetic retinopathy postoperatively. 
Progression that is observed probably represents the natural history of 
the disease rather than being a direct effect of surgery61. Clinically 
significant macular edema present in diabetic eyes at the time of cataract 
surgery is unlikely to resolve spontaneously, but clinically significant 
macular edema arising after surgery commonly resolves, particularly if 
retinopathy is mild as shown by natural history24. 
           Compared to non-diabetic patients, outcome after cataract surgery 
was reported to be worse in diabetic patients--especially in those with 
diabetic retinopathy. 
COMPLICATIONS  OF CATARACT SURGERY 
The possible complications that can arise in a diabetic during 
cataract surgery2 are as follows : 
1) Bleeding 
2) Poor dilatation 
3) Delayed epithelisation 
4) Iritis 
5) Possible effect on diabetic retinopathy 
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6) Insufficient wound closure 
7) Infection  
8) Increased blood sugar caused by topical / general steroid 
Minimum invasion is essential to avoid complications of surgery 
and surgery is often complicated by poor dilatation.  Avoiding excess 
contact with iris decreases post operative inflammation and unexpected 
bleeding in AC. 
If vitrectomy was performed, surgeon should be prepared for 
unstable AC  pre-existing rupture of PC.  
If PRP planned, large anterior capsulotomy and optic diameter 
should be used. 
I) Inadequate Pupillary Dilatation 
 This is a common occurrence in cataract surgery  in diabetics.  
This can be managed by using  
1) Retraction of the pupil by self  retaining, titanium Iris hooks. 
2) Iris protector ring  
3) Sphincterotomies. 
The use of capsular dye trypanblue or ICG is recommended for 
improved capsular visualization in any white cataract51.   
  
33 
II) Shallow anterior chamber : 
Intraoperatively it may be due to  
- Inadequate infusion into the AC 
- Leakage through oversized wound 
- External pressure on the globe 
- Positive vitreous pressure 
- Suprachoroidal hemorrhage or effusion 
- Posterior effusion syndrome - Common during hydro dissection; 
fluid infused into the AC may be misdirected into the vitreous cavity, 
causing an increase in the vitreous volume, with subsequent forward 
displacement of the lens and shallowing of the AC. 
Post operative : 
- Wound leak 
- Choroidal detachment 
- Pupillary block 
- Ciliary block 
- suprachoroidal hemorrhage 
III. Corneal edema  
Undue surgical stress on a compromised diabetic cornea can lead to 
corneal oedema commonly. 
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1. Stroma and epithelial edema (< 1% in general) : 
Stromal or epithelial edema may occur in the immediate 
postoperative period preexisting corneal endothelial dysfunction causes 
an increased incidence of edema. Mechanical trauma, inflammation, 
increased IOP and prolonged irrigation are factors resulting in acute 
endothelial decompensation which causes corneal edema. Generally 
resolves in 4-6 weeks. Peripheral corneal edema resolves with times as a 
rule. Corneal edema after three months does not clear. 
2. Vitreocorneal Adherence – Persistent Corneal Edema 
           Vitreocorneal adherence is an early / late complication. Advanced 
cases may need combined vitrectomy with a penetrating keratoplasty. 
3. Descemet’s Membrane Detachment : 
         This results in stromal swelling and epithelial bullae localized to 
the area of detachment. This complication can result due to trauma 
caused by an instrument or IOC introduced through the incision or when 
fluid is injected between Descemet’s membrane and corneal stoma.  
4. Toxic solutions : 
         Some solutions used for either irrigation or inadvertent entry into 
AC can be toxic to the corneal endothelium and cause temporary or 
permanent corneal edema. Chlorhexidine used to clean the skin can 
cause irreversible corneal damage. 
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5. Brown Mclean syndrome : 
          This is a clinical condition consisting of peripheral corneal edema 
with a clear central cornea. More frequent after ICCE. Edema starts 
inferiorly and progresses circumferentially but spares the central cornea. 
The etiology is unknown. 
IV. Hemorrhage 
1. Hyphema :  
Postoperative hyphema originates from the incision or the iris. If 
vitreous is mixed with blood, it takes a longer time to resolve. Prolonged 
hyphema can lead to elevated IOP and corneal blood staining.  
2. Retro bulbar Hemorrhage 
 More common with retro bulbar anesthetic injections. Venous RB 
hemorrhage is self limited and spreads slowly, often requiring no 
treatment. Arterial RB hemorrhage occurs rapidly  and is associated with 
taut orbital swelling, proptosis and raised IOP, reduced mobility of the 
globe. It is diagnosed by the rapid onset of lid and conjunctival 
ecchymosis and tightening of the orbit. 
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3. Suprachoroidal hemorrhage or effusion : 
 It occurs generally intra operatively. This complications can be 
diagnosed by a forward prolapse of posterior ocular structures including  
the iris and vitreous, associated with a change in the red reflex. These 
complications are more common in the presence of hypertension, 
obesity, high myopia, glaucoma, anticoagulation or chronic ocular 
inflammation. Suprachoroidal effusion may be a precursor of 
suprachoroidal hemorrhage. 
4. Expulsive suprachoroidal hemorrhage : 
 This is rare, but a grave complication presents as sudden increase 
in IOP accompanied by darkening of red reflex gaping of wound, iris 
prolapse expulsion of the lens, vitreous and bright red blood or sudden 
onset of pain. As soon as it is diagnosed, wound must be closed with 
suture or digital pressure. Posterior sclerotomy allows escape of blood. 
Delayed suprachoroidal hemorrhage may occur in early post operative 
period. 
V. Posterior Capsular Rupture : 
 The first signs of capsular rupture may be a sudden deepening of 
the AC. In a small rent, residual cortex is removed followed by PCIOL 
implantation without disruption of the anterior hyaloids face. If the PC 
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rent is large and anterior hyaloid face is broken, a vitrectomy followed 
by implantation of IOL is recommended. 
VI. Vitreous disruption : 
 Vitreous can enter the AC through the pupil as a complication of 
cataract extraction by any technique. The presence of vitreous may be 
detected by touching the wound or iris with a cellulose sponge. Vitreous 
in the AC may lead to chronic ocular inflammation with or without 
CME. Pupil may be distorted exposing the edge of the IOL with 
resultant glare. Vitreous in the wound can lead to ‘vitreous wick 
syndrome’ wherein endophthalmitis sets in due to entry of bacteria 
through the vitreous in the wound. 
VII. Elevated IOP : 
 It is common following cataract surgery. The possible reasons are 
viscoelastic substances behind the lens implant or in the posterior 
chamber. Pupillary block, ciliary block, hyphaema, retained lens 
material, endophthalmitis, release of iris pigments, steroid use, PAS, 
preexisting glaucoma are reasons for raised IOP. 
VIII. Iridodialysis : 
 Tearing of iris at its insertion occurs due to manipulation of 
intraocular tissues. If extensive, needs permanent monofilament 
suturing. 
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IX. Cyclodialysis : 
 Separation of the ciliary body from its insertion at the scleral 
spurs due to manipulation of tissues.  
X. Endophthalmitis : 
- Acute → 2-5 days post operatively, runs a fulminant course. 
Decreasing vision and increasing pain and inflammation are 
characteristic. 
- Chronic → weeks to months after surgery. This is characterized by 
chronic iritis and granulomatous reaction 
-  Non infectious toxic endophthalmitis is a rare complication due to 
introduction of toxic materials into the eye 
- It occurs in 0.07 to 0.22 % 
XI. Chronic uveitis : 
 Patients develop chronic uveitis weeks or months after surgery. 
The response to steroids is variable. It is has been reported in association 
with low grade bacterial pathogens like propionobacterium acnes and 
staphylococcus epidermiditis.  
XII. Retained lens material : 
 Patients with retained lens material present with variable degrees 
of inflammation depending on the size of the lens fragment; type of 
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material and time elasped since surgery. Clinical signs are uveitis, 
glaucoma, corneal edema and vitreous opacities.  
XIII. Cystoid macular edema : 
 CME is a common cause of diminison of vision after both 
complicated and uncomplicated cataract surgery (Irvine Gass 
syndrome). Increased perifoveal capillary permeability associated with 
intraocular vascular unexplained reduction of visual acuity 6-10 weeks 
after surgery. Common following ICCE & PCR. Diabetes mellitus is a 
risk factor for CME. Other factors are post-op-inflammation, preexisting 
epiretinal membrane. Malpositioned implants, vitreous adhering to the 
incision, iritis or IOL. The risk of CME can be reduced by pre-and post 
operative  use of topical 5% ketorolac. 
XIV. Posterior Capsular Opacification (PCO) 
In 1998 a meta-analysis showed PCO rates of 11.8%after one 
year 20.7% after 3 years and 28.4% after 5 years.  Lens epithilial cells 
are a continuous single cell line.  Functional and pathological groups – 
‘A’ cells and ‘E’ cells.  ‘A’cells proliferates and forms fibrous tissue by 
undergoing fibrous metaplasia.  ‘E’ cells are the primary source of pearl 
form of PCO.  Bladder / Wedl cells are swollen opacified epithelial 
pearls. 
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Factors to reduce to PCO  
1. Hydro-dissection enhanced cortical cleanup.  
2. In the bag fixation. 
3. Small CCC with edge on IOL. 
4. Biocompatable IOL to reduce cellular  proliferation. 
5. Maximal IOL-PC contact, angulated haptic. 
6. IOL optic geometry square, truncated edge. 
Wound deshicence occurs at the rate of 0.02 – 1.5%.  and it is 
more common in diabetics.  
Cheng et al17 reviewed the results of cataract surgery in diabetic 
patients and the visual outcome was good in the absence of retinopathy 
and was not significantly different from that of non-diabetic patients. 
Eyes with retinopathy achieved significantly worse visual results and the 
prognosis was related to the severity of retinopathy. Clinical cystoid 
macular edema occurred significantly more frequently in eyes with 
retinopathy than without and there were significantly more eyes with 
retinopathy which became blind or partially sighted. Modern cataract 
surgery seems to have no influence on the progression of diabetic 
retinopathy. A visual improvement is achieved in the majority of 
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patients with NPDR, but poorer visual outcome is observed in patients 
developing macular edema. 
Pollack A et al52 in their study showed the course of cystoid 
macular edema (CMO) following extracapsular cataract extraction with 
posterior chamber intraocular lens implantation was prospectively 
studied in 44 eyes of 44 consecutive diabetic patients without 
preoperative CMO. In 50% of eyes CMO was observed 6 weeks after 
surgery and in 25% was still present at 1 year. The preoperative 
presence of diabetic retinopathy significantly affected the postoperative 
onset and persistence of CMO. They believe that cataract extraction 
should not be recommended for eyes with pre-existing diabetic 
retinopathy until the vision has deteriorated to at least 6/30-6/60. 
Gupta A et al29 in their study showed patients with diabetic 
mellitus have an increased risk of developing cataract. Many such 
patients have pre-existing diabetic retinopathy at the time of cataract 
surgery Although more than 90% of the patients who have no pre-
existing diabetic retinopathy carry a good visual prognosis and 
eventually have 20/40 or better visual acuity, nearly one-third of patients 
with pre-existing retinopathy may show retinopathy progression. 
Postoperative angiographic macular edema is more common in patients 
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with diabetes but resolves spontaneously in patients with no or minimal 
diabetic retinopathy. In patients with moderate to severe NPDR or more, 
clinically significant macular edema tends to persist, may arise de-novo, 
or even worsen after cataract surgery. Patients with diabetes need a 
preoperative characterization of their retinopathy and a thorough 
discussion with the patient about the need for cataract surgery, and the 
risk of progression of retinopathy is mandated. Currently, early surgery 
is favored before the development of significant diabetic retinopathy 
rather than wait for the cataract to become denser. All efforts should be 
made to stabilize diabetic retinopathy with appropriate laser treatment 
before cataract surgery. All diabetic patients need close observation for 
at least 6 months following surgery to intervene with laser 
photocoagulation as and when required to prevent visual loss from 
diabetic maculopathy and other consequences of diabetic retinopathy. 
Menchini U et al 47,48 in their study showed diabetes is a risk 
factor for the development of cataracts. Studies have shown an increased 
risk of ocular complications in diabetics after cataract surgery, but 
modern surgical techniques have minimized them, leading to an overall 
good visual outcome. Macular edema before surgery is the most 
common condition that limits post-operative visual recovery. Thus, pre-
operative laser treatment is needed. Photocoagulation of preproliferative 
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or early proliferative diabetic retinopathy is also advisable, due to the 
increased risk of iris neovascularization or retinopathy progression after 
surgery. 
Kutschan A et al44  investigated whether cataract surgery in 
patients with diabetes mellitus influences the progression of diabetic 
retinopathy, diabetic macular edema and anterior segment 
complications. Insufficient pupil dilatation (25.2 %) was the most 
frequent intraoperative complication. Among early postoperative 
complications anterior segment inflammation was most frequent (10.1 
%). During the follow-up period the diabetic retinopathy in the operated 
eyes showed a progression which was statistically not different from that 
in the non-operated eyes. A diabetic macular edema was present after an 
average of 19 months in 6.8 % of the operated 119 eyes and after an 
average of 38 months in 6.7 % of the operated 88 eyes. The main late-
complication during the whole follow-up period was the development of 
a capsular fibrosis in 52.3 % of the operated eyes. Postoperative visual 
acuity at the end of the first follow-up period (average 19 months) was 
>/= 0.5 in 85.7 % of the operated eyes and at the end of the second 
follow-up period (average 38 months) in 81.8 % of the operated eyes. 
Thus they concluded that extracapsular cataract surgery in patients with 
diabetes mellitus is a procedure with good results, of high reliability and 
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a slightly higher rate of complications than in non-diabetic patients. 
Extracapsular cataract surgery does not give rise to progression of 
diabetic retinopathy. 
Straatsman BR et al62  in their study with prospective evaluation 
of extracapsular cataract extraction with posterior chamber intraocular 
lens (ECCE-posterior chamber IOL) in 234 eyes of 20 diabetics, with 
and without nonproliferative retinopathy, and 209 nondiabetics 
demonstrated no statistically significant difference in operative or 
postoperative complications. A postoperative final visual acuity of 20/40 
or better was achieved in 65% of diabetic surgical eyes and in 90% of 
nondiabetic surgical eyes, a difference that was statistically significant 
(P = 0.0049). When eyes with diabetic retinopathy or other pre-existing 
ophthalmic disease responsible for decreased vision were excluded, 
postoperative visual acuity of 20/40 or better was obtained in 93% of 
diabetic eyes and 96% of nondiabetic eyes, a difference that was not 
statistically significant (P = 0.5045). Therefore, the relatively less 
favorable outcome of ECCE-posterior chamber IOL surgery in diabetics, 
with or without nonproliferative retinopathy, is due to greater frequency 
of retinopathy or other ophthalmic disease responsible for decreased 
vision 
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Raskauskas PA et al53 studied diabetic patients undergoing small 
incision cataract surgery . One hundred fifty-four eyes of diabetic 
patients were evaluated preoperatively through dilated fundus 
examination and Snellen visual acuity. The eyes then underwent small 
incision cataract surgery and were followed, undergoing periodic 
ophthalmoscopy, Snellen visual acuity measurement and additional 
postoperative therapeutic and surgical intervention. Final visual acuity 
improved by two Snellen lines or more in 61 out of 154 (40%) eyes. 
Final visual acuity worsened in 38 out of 154 (25%) eyes. They 
concluded the results are similar to those reported for extracapsular 
surgery and phacoemulsification, suggesting that the prognosis is 
guarded for diabetics, even when undergoing small incision cataract 
surgery. 
Tsujikawa A et al64 retrospectively studied 255 eyes of 190 
diabetic patients who underwent cataract extraction with posterior 
chamber intraocular lens (IOL) implantation. One hundred forty-six eyes 
(57.3%) achieved the best visual acuity of 20/30 or better and 221 eyes 
(86.7%) achieved the acuity of 20/100 or better. The results suggested 
that the progression of diabetic retinopathy after IOL implantation was 
correlated with diabetic control at the time of surgery. Additionally, 
patients who developed the progression of the retinopathy in 
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pseudophakic eyes frequently showed the progression in the fellow 
unoperated eyes. 
Tsujikawa A et al65   in their retrospective study of 140 eyes of 
102 patients, 97 eyes (69%) achieved a best visual acuity of 20/40 or 
better. After a minimum 6-month postoperative period, 26 eyes (19%) 
had developed retinopathy: eight eyes progressed from nonproliferative 
to proliferative retinopathy. Glycosylated hemoglobin levels and fasting 
blood glucose were significantly higher at time of surgery in the eight 
that progressed than in those who did not (P = 0.002, P = 0.034). There 
were 65 unilateral IOL implantations; in 10 (15%) of these eyes, 
retinopathy progressed. Retinopathy also progressed in 70% of the 
fellow eyes of these patients. In patients whose retinopathy did not 
progress, 95% of the fellow eyes also showed no progression. Also, 
patients with progression in the pseudophakic eye frequently had 
progression in the fellow unoperated eye. Postoperative progression was 
symmetrical (P = 0.0001). Their analysis suggests that progression of 
diabetic retinopathy following IOL implantation can be correlated to 
diabetic control at the time of surgery. 
Chiselita D et al19  in their retrospective study including 100 non-
diabetic patients and 50 patients with type II diabetes, with extracapsular 
extraction and IOL implantation in the postoperated chamber followed 
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for 10.3-7.3 months postoperative complications. Their results showed 
that postoperative visual acuity was lower in diabetic patients (0.317 +/- 
0.24) versus non-diabetic patients (0.634 +/- 0.30); postoperative visual 
acuity was lower in diabetic patients without retinopathy (0.437 +/- 
0.26) versus diabetic patients with non-proliferative retinopathy (0.348 
+/- 0.26) or diabetic proliferative retinopathy (0.116 +/- 0.11); the 
incidence of per- and postoperative complications (early and late) is 
higher in diabetic patients compared with the control group. Hence 
cataract surgery in diabetic patients is followed by higher rate of per- 
and postoperative complications. The postoperative functional result is 
dependent, in principal, on the retinal status of the diabetic patient and, 
secondary, on the per- and postoperative complications. 
Gabric N et al28 recommended cataract operation (ECCE + 
PCIOL) to be a well tolerated surgical procedure in diabetic patients 
with lenticular opacity, in whom it should be even earlier performed 
than in nondiabetics, because cataract prevents the diagnosis or 
treatment of a suspect retinal disorder. 
 Cataract is a common complication of diabetes indeed it has 
been estimated that up to fifteen per cent of cataract surgery is 
performed on diabetics. The main indications for surgery are the same as 
for non-diabetic patients. In addition, surgery is indicated if the lens 
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opacity prevents an adequate examination of the fundus or produces 
excessive scatter of light during laser therapy. Standard surgical 
techniques are applicable e.g. Extracapsular cataract extraction or 
phacoemulsification. with posterior chamber intraocular flexible or non-
flexible lens implantation. If phacoemulsification is performed, it is 
advisable to perform a large capsulorrhexis with a 7mm optic lens, thus  
allowing the better visualization of the fundus for PRP if required. 
Following surgery, the incidence of capsular opacification is greater in 
diabetics than in non-diabetics. Therefore, a large YAG capsulotomy to 
improve vision or improve visualization of the retina may become 
necessary. The results of surgery  best in those eyes with no retinopathy 
and worst in those eyes with active proliferative retinopathy. 
Other rare complications of cataract surgery include  
• Retinal detachment 
• Macular infarction 
• Pupillary capture 
• Epithelial down growth 
• Induced astigmatism 
• Capsular opacification and contractions 
• Dislocation or decentering of IOL 
• UGH syndrome 
• Induced astigmatism 
• Retinal light toxicity 
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MATERIALS AND METHODS 
This prospective study was carried out in the Department of 
Ophthalmology, Stanley Medical College & Hospital, Chennai, from 
October 2003 to December 2005. One hundred patients having diabetes 
who presented to our department for cataract surgery were included in 
the study. 
Inclusion criteria 
• Patients having biochemically proven diabetes mellitus 
• Complete or partial Opacification of the lens or capsule with 
visual acuity of less than or equal to 6/24 
• Good glycemic control pre operatively by either insulin or oral 
hypoglycemics or diet or in combination 
• Patients willing to undergo cataract surgery 
• Age greater than 40 years 
Exclusion criteria: 
• Diabetic patients with poorly controlled glycemic status 
• Partial lens opacification with V/A better than 6/24 
• Patients not willing to undergo cataract operation 
• Age less than 40 years 
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Pre-operative evaluation : 
All the patients included in the study were subjected to a detailed 
preoperative evaluation as follows : 
Detailed history regarding duration of diabetes, type, nature of 
treatment, associated systemic conditions, pro-diabetic states were 
noted. A detailed ophthalmic evaluation was done by oblique 
examination, slit lamp examination and the fundus examination was 
carried out by using direct and indirect ophthalmoscopy and slit lamp 
biomicroscopy using + 78 D lens.   
Ocular evalulation was done with special regard to changes in the 
ocular structures due to diabetes.  Diabetics are more prone to develop 
infective conditions of the lids and adnexa, tear film abnormalities, 
keratopathy, keratoepitheliopathy, motility disorders (cranial nerve 
palsy).  Pupillary responses were checked as RAPD could be due to 
diabetic papillopathy or other  causes.  IOP measurement, evaluation for 
POAG and neovascular glaumcoma were done as there is an association 
between POAG and diabetes.  A routine gonioscopy was done in all 
patients to detect any neovascularisation or other abnormalities. 
The morphology of the cataract was evaluated using a slit lamp.  
Fundus examination was done to assess the retina and diabetic 
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retinopathy status if present.  In a dense cataract obscuring the media, B-
scan, USG was done to assess the integrity of the retina.  
Preoperative refraction is useful in planning the IOL power 
necessary to obtain the postoperative refraction desired by the patient.  
A-scan biometry was used to calculate the appropriate IOL power.   
           Intraoperative details including the type of surgery, IOL and the 
type of IOL, complications during surgery were noted. Postoperative 
details included the immediate post operative complications, V/A at 48 
hours and the late post operative complications including progression of 
retinopathy and the final BCVA were noted.  Patients with systemic 
illness were treated appropriately in the respective speciality 
departments prior to surgery. 
           All patients underwent cataract operation under local anaesthesia.  
All patients were admitted on the day before surgery and were 
discharged on the second day unless there was associated post operative 
complication deserving inpatient management. Preoperative fasting 
blood glucose was checked and those with poor glycemic control were 
referred to the diabetologist for appropriate treatment before embarking 
on cataract surgery. Patients with associated other ocular co morbidities 
were dealt with appropriately at the same time of cataract surgery e.g for 
glaucoma, pterygium.  All the patients who were operated during the 
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specified time period irrespective of the status of surgeon were included 
in our study. Both the conventional types of cataract surgery i.e. ECCE 
and SICS were included in the study  since phacoemulsification was not 
being done in our hospital for technical and financial reasons. 
Combination of topical antibiotic steroids, cycloplegics were 
used routinely for 6 weeks during the post operative period.  Tear 
substitutes, prednisolone acetate were used when necessary. 
          All the patients were subjected to a pre-operative visual acuity 
testing using a Snellen`s chart. The same was repeated in 48 hrs post-
operative and refraction was done in the late post operative visit in 6 
weeks time. The incidence of complications each in separate time 
interval from intra operative, early post operative  and the late post 
operative were noted. The final outcome of surgery and the patient 
satisfaction were also noted.  
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OBSERVATIONS AND RESULTS 
 In this study the following are the observations and analysis 
made :  
 Age:  the incidence of cataract with regard to age in the study 
conduced is stratified as follows. 
Table 1 
Age Incidence 
 
Age No. of patients Percentage 
40 – 50 years 18 18 
51 – 60 Years 47 47 
61 – 70 years 29 29 
> 71 years  6 6 
47% of the patients were between 51 – 60 years and hence they 
constitute the majority in the study group.  29% were between 61-70 
years followed by 18% 40-50 years. 
 
Table 2 
Sex Incidence  
 
Sex No. of patients Percentage 
Males 33 33 
Females 67 67 
Among the 100 cases who underwent cataract surgery, 33% were 
males and 67 % were females.   
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Table 3 
Incidence of Cataract Morphology 
Morphological characteristics of each cataract was studied by 
detailed slit lamp examination before surgery and it is as follows.  
Morphology Percentage Subtypes 
Cortical 80% 54% Immature 
23% Mature 
3% Hypermature 
Nuclear 16%  
Posterior subcapsular 3% 1% Polychromatic Lustre  
2% Bread Crump  
Anterior subcapsular 1% 1% Snowflake cataract 
The majority shows cortical changes (80%).  Hypermature and 
mature constitute 26% which is because of the low socio economic 
status of the study group.  Nuclear sclerosis was found in 16% and 
posterior subcapsular cataract in 3% of which 1% was poly chromatic 
luster and 2% had bread crump appearance.  The typical snow flake  
diabetic cataract was found only in 1%.  
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Table 4 
Systemic Association – Incidence 
 
The incidence of other systemic associations in this study group 
of diabetics is as follows. 
Systemic Association No of patients Percentage 
Hypertension 16 16% 
Ischemic heart disease 6 6% 
Asthma 3 3% 
Obesity 3 3% 
Hypothyroid  1 1% 
 
Hypertension (16%) was found to be the most commonly 
associated systemic condition in the study group followed by 6% 
ischemic heart disease.  Asthma and obesity had an association of 3% 
each.   
Table 5 
Pre operative Glycemic control 
 
Mode of treatment No. of cases Percentage 
OHA & Diet 6 6% 
Insulin 11 11% 
OHA & Insulin 83 83% 
The majority (83%) were treated by OHA and insulin because of 
the poor compliance of these patients.  The rest 11% were treated with 
insulin.  OHA and diet played only in minor role in this study group.   
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Type of diabetes  
Among the 100 diabetic patients 97% were diagnosed type 2 DM, 
2% as type 1 and 1% as MODY.   
Table 6 
Duration of diabetes 
 
Duration No. of patients Percentage 
< 2 years   25 25% 
3-5 years 45 45% 
6 – 10 years 28 28% 
>10 years 2 2% 
 
45 % of the cases were diabetic for period of 3 – 5 years.  28% 
were known diabetics for 6-10 years.  25% of this diabetic population 
were detected < 2 years.  Only 2 % of the patients were diabetics for 10 
years or more.  
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Table 7 
Ocular Comorbidity 
 
Coexisting ocular comorbidities in these diabetic patients who 
underwent cataract extraction are as follows.  
 
Disease No. of patients Percentage 
POAG  2 2% 
Phacomorphic Glaucoma 2 2% 
Uveitis 2 2% 
ARMD 2 2% 
Corneal opacity 1 1% 
Iris coloboma 1 1% 
Phacolytic Glaucoma 1 1% 
Macular Hole 1 1% 
HT Retinopathy 1 1% 
Ocular allergy 1 1% 
Primary open angle glaucoma was found in 2% of this study 
group.  Other coexisting eye disease are purely co incidental.   
  
58 
Table 8 
Intraoperative complications 
Complication arising due to cataract surgery intra operatively are 
as follows: 
Complication No. of patients Percentage 
Intra operative Miosis 12 12% 
Posterior Capsule Rent 6 6% 
Zonulodialysis  2 2% 
Vitreous loss 8 8% 
Excessive pigment release 3 3% 
Bleeding from iris  1 1% 
SCH during anaesthesia  1 1% 
Iris Tear 2 2% 
Retained lens material  1 1% 
Primary PCO 1 15 
Calcified anterior capsule 1 1% 
Intra operative miosis was the most commonly occuring intra 
operative complication (12%).  Posterior capsule rent occurred in 6% of 
patients.  Vitreous loss due to PCR and ZD was 8%.  Bleeding was the 
next common complication, SCH in 1%,  iris bleeding 1%. Excessive 
release of iris pigments was found in 3 %.   
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Table 9 
Post operative complications – 48 hours 
Complications No. of patients Percentage 
Corneal edema 19 19% 
Post operative inflammation 
(Iritis) 
10 10% 
Retained cortical material 3 3% 
Raised IOP 4 4% 
Iris Prolapse 2 2% 
Hyphaema 1 1% 
Wound leak 1 1% 
IOL Malpositon 1 1% 
Vitreous in wound 1 1% 
Peri orbital bruise 1 1% 
Reactivation choroiditis 1 1% 
Supra choroidal haemorrhage 1 1% 
 
Corneal edema in 19% was the most commonly occurring  
immediate post operative complication .  Post operative iritis in 10% 
occurred in this study group.  Raised IOP was found in 4% of patients.  
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Table 10 
Long term complication 
 
Complication No. of patients Percentage 
Cystoid macular edema 4 4% - Aphakia 3% 
      - Pseudophakia 1% 
Recurrent uveitis 2 2% 
Prolonged RIOP 2 2% 
Cyst at wound site 1 1% 
PCO  2 2% 
Evisceration  1 15 
 
Macular edema occurred in 4% and this was the common long 
term complication in the study out of which 3% were aphakic and 1% 
pseudophakic.  Recurrent uveitis occurred in 2%.  PCO incidence could 
not be calculated exactly because long term follow up was not possible.   
 
Table 11 
Visual acuity – 48 hours after surgery 
 
Visual Acuity No. of patients Percentage 
< 6/60 16 16% 
6/60 – 6/36 29 29% 
6/24 – 6/18 36 36% 
6/12 – 6/6 18 18% 
PL/PR negative 1 1% 
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Table 12 
Best corrected visual acuity BCVA – 6 weeks 
Visual Acuity No. of patients Percentage 
< 6/60  10 10% 
6/60 – 6/36 4 4% 
6/24 – 6/18 17 17% 
6/12 – 6/6 68 68% 
PL/PR negative 1 1% 
 
Nearly 68% of the cases in this study achieved a V/A of 6/12 or 
better.  The post operative V/A in the rest 32% was less because of the 
complications and other eye diseases.   
Table 13 
BCVA with age in percentage 
Age < 6/60 6/60 – 6/18 6/12 – 6/6 
40 – 50 years 1 1 16 
51 – 60 years 6 6 32 
61 – 70 years 4 10 17 
> 71 years - 4 3 
 
ECCE was performed in 36% and SICS in 64% of the patients.  
Bilateral simultaneous cataract surgery was done in 16% of cases within 
a week.   
Only in 2 patients (2%)  progression of diabetic retinopathy was 
observed and progression was responsible for diminished BCVA in 1% 
only. 
In 94% of the cases PCIOL implantation was done.  In 5% 
patients were left aphakic and ACIOL was implantated in 1% of the 
patients.  
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DISCUSSION 
The incidence of cataract with regard to age was evaluated and 
this study shows that early half (47%) of the patients are between the 
age 51 – 60 years.  This correlated with the health and nutrition 
examination surgery (HANES) and the Framingham study that there is 
an increased risk of age related cataract development in diabetic less 
than 65 years old.  In the Wisconsin study of diabetic retinopathy 31 of 
the younger onset patients and 76% of older onset patients not taking 
insulin had visual impairment due to causes other than retinopathy 
cataract being the commonest cause.  Females constituted the majority 
67% in the study.  Gender standardized prevalence of diabetes in 
Chennai showed that, it is higher in females14. 
Nearly 80% showed cortical changes.  A cataract having a 
characteristic age – related clinical appearance especially in terms of 
cortical and subcapsular changes, is more common adult diabetes, 
particularly women.  Nuclear changes occurred in 16%, PSCC in 3%.  
ASCC in 1%.  Central nuclear sclerosis and posterior subcapsular 
cataracts occur with equal frequency in diabetic and non-diabetics 
patients, anterior subcapsular cataracts seem to be more frequent in 
diabetics7.  Among the PSCC, one was due co-existing chronic uveitis. 
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The classical ‘snowflake’ diabetic cataract  with an appearance of 
white subcapsular spots forming dense band was found only in one 
patient, who was a forty year old female with MODY. 
Hypertension 16% was the most common systemic association in 
this study group followed by ischemic heart disease 6%.  Asthma and 
obesity had an association of 3% each. 
Pre operation glycemic control was achieved by either OHA and 
diet, insulin or OHA and insulin.  The vast majority were treated by 
OHA and insulin (85%) because of the poor compliance of  these 
patients as the study group belonged to a low socio economic strata.  
Regular insulin was used when plasma glucose was more than 300 
mg/dl and good glycemic control was achieved by titrating the insulin 
dosage according  to the plasma glucose levels.  Among the hundred 
diabetics, 97% were diagnosed as type 2 DM and 1% as type 1 and 1% 
as MODY.  The prevalence of type – 2 DM in Chennai was 11.6%.  the 
duration of diabetes is a crucial factor in the pathogenesis of diabetic eye 
disease 45% of the case were diabetics for 3-5 years, 25% were diabetics 
less  than equal to 2 years and 28% were diabetics for 6-10 years. 
Co-existing ocular co-morbidities were as follows.  2% were 
diagnosed to have POAG and a combined cataract extraction with 
trabeculectemy was performed.  Most of the literatures are equivocal 
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about an association between diabetes and POAG.  This was 
investigated as a part of the Blue Mountains Eye study and the results 
indicated that there was a real association between the two condition.  3 
cases of lens induced glaucoma, out of which two were phacomorphic 
glaucoma and one was a phacolytic glaucoma were operated after 
control of IOP.  1% had chronic anterior uveitis which was operated 
under good steroid cover.  Another 1% had a reactivation of choroiditis 
after cataract surgery.  The other co-existing ocular conditions like angle 
closure glaucoma, macular hole, ARMD, HT retinopathy, corneal 
opacity and ptergium were purely co-incidental. 
Local anesthesia was used in all patients who underwent cataract 
surgery. Cataract surgery under LA provides improved metabolic 
control for the diabetic patient.  Its used maintains glucose homeostasis 
– prevents the increase in cortisol and glucose which are seen under GA 
and obviates the need for post-operative starvation35. 
Intra operative complication were noted in all the patient and 
intra operature miosis 12% is the most common complication arising 
this study group.  Kutschan A et al found insufficient pupil dilation 
25.2% was the most common intra operative complication in diabetics44.    
Zaczek A. et al68 studied the pupil size in patients with diabetes mellitus 
during cataract surgery and concluded that constriction during surgery is 
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more pronounced in diabetic eyes as compared to controls.  Due to 
ineffective mydriasis, the entire surgical procedure was pronounced as 
compared to non diabetics.  Out of 12 patients with intra – operative 
miosis, four ended with complication like posterior capsule rent in 2%, 
Zonulodialysis in 1% and pigment release due to excessive manipulation 
while placing the PCIOL. 
Subconjunctival haemorrhage with chemosis occurred in the 
lower quadrant during peribulbar anaesthesia in one patient.  Posterior 
capsular rent occurred in 6%, zonulo dialysis 2% and hence vitreous loss 
occurred in 8% patients.  This is higher compared to the incidence of the 
complication in non-diabetics when PCR occurred on 3.1% and vitreous 
loss in 0.8%.  Excessive pigment release occurred in 3% and is a 
common occurrence in diabetics due to the nature of the iris in diabetes.  
Lamellar changes, cytoplasmic vacuolation, lipid droplet accumulation 
were noted in the iris mucles. Nerve fibres frequently diminished in 
diabetic patients63.   
A record of post operative complications in this study showed 
that corneal odema (19%) was found to be the most common post 
operative complication occurring in the first 48hours.  Diabetic cornea 
has reduced sensitivity and undue stress can lead to 
keratoepitheliopathy34.  The reduction of expression of entactin / laminin 
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– 1, and 10, and of their binding α3β integrin in diabetic retinopathy 
cornea may severely impair  adhesive and migratory properties of 
corneal epithelial cells.  Such alteration in the corneal cell BM adhesion 
may be the mechanism underlying clinically observed abnormalities in 
epithelial barrier function, adhesion, epithelial integrity and wound 
healing13.    Raised IOP also contributes to this increase in the number of 
post-operative corneal edema.  Bleeding in AC had occurred in 1% post 
operatively and 1% intra operatively.  Bleeding is a common 
complication arising in diabetics due to the nature of the diabetic tissue.  
The rate of post operative inflammation was 10% in this study, when 
compared to non-diabetics 1.8%.  Retained lens material in 3% 
especially the superior cortical material was due to inadequate 
mydriasis.  One of the patient, a fifty year old female developed 
expulsive supra choroidal haemorrhage on the second post operative 
day.  She was diagnosed to have phacolytic glaucoma with 
hypertension.  Evisceration was done to remove the prolapsed uveal 
tissue and hence prevent sympathetic ophthalmitis. 
Menchini U et al47,48 showed an increased risk of ocular 
complication in diabetes after cataract surgery but modern surgical 
techniques have minimized them, leading to overall good visual 
outcome.  Kutschan A et al in study said, among early post operative 
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complications, anterior segment inflammation was most frequent 
(10.1%)44. 
In this study macular edema was the common long term post 
operative complication in 4% as compared to other 1.4%.  recurrent 
uveitis occurred in 2% and one among them had an ACIOL implanted.  
1% developed a dense exudative membrane which caused  gross  vision 
loss.  PCO occurrence is 19% in general population after 1 year.  Since 
patients could not be followed up for a long period, the exact incidence 
could not be detected.   
Visual acuity outcome was studied and BCVA after 6 weeks of 
surgery was such that 68% achieved a V/A of 6/12 or better.  The 
remaining 32% had BCVA less than 6/12 which was due to the 
complications of surgery and the co-existing ocular co-morbidities.   
Macular edema was responsible for V/A < 6/60 in 4%.  Corneal 
edema with RIOP in 3%, chronic corneal edema in 3% hyphema in 1% 
had BCVA of 5/60 and 1% had 6/24.  recurrent uveitis was also 
responsible for diminished vision.   
Kutschan A et al studied that diabetic macular edema was present 
after an average of 19 months in 6.8%.  Cheng et al17 found clinical 
cystoid macular oedema occured significantly more frequently in eyes 
with retinopathy than without.  Pollack A et al52 in the study showed that 
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in 50% of eyes CMO was observed 6 weeks after surgery and in 25% 
was still present at 1 year.  The pre operative presence of diabetic 
retinipathy significantly affected the post operative onset and persistence 
of CMO.  Gupta et al 29 studied that post operative angiographic macular 
edema is more common in patients with diabetes but resolved 
spontaneously in patients with no or minimal diabetic retinopathy.   
ECCE was performed 36% and SICS 64%.  Bilateral 
simultaneous cataract surgery was done in 16 cases within a gap of one 
week. Gabric N et al 28 recommended cataract operation (ECCE + 
PCIOL) to be a well tolerated surgical procedure in diabetic patients 
with lenticular opacity, in whom it should be even earlier performed 
than in nondiabetics, as it prevents the diagnosis or treatment of a 
suspect retinal disorder. 
Raskauskas PA et al53 studied diabetic patients undergoing SICS 
and concluded that the results are similar to those reported for extra 
capsular surgery and phacoemulsification   suggested that prognosis is 
guarded for diabetics even when undergoing SICS.   
Single piece biconvex mod.C step vault PCIOL with 6.50mm 
optic of PMMA material with UV absorbing optic was used in this 
study. 
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Tsujikawa A et al64 suggested that the 57.3% achieved the BCVA 
of 20/30 or better and 86.7% achieved the acuity of 20/100 or better.  
Straatsman BR et al62 demonstrated of final visual acuity of 20/40 or 
better was achieved in 65% of diabetic surgical eyes and in 90% non 
diabetic surgical eyes, a difference that was statistically significant 
(P=0.0049).    
Retinopathy progression on occurred only in 2%.  Gupta et al29 
suggested that patients with diabetes need pre operated characterization 
of the retinopathy and discussion with the patients about the need of 
cataract surgery and risk of progression of retinopathy is mandated.  
Early surgery is favoured before the development of significant diabetic 
retinopathy. 
Stratsman BR et al62 said when eyes with diabetic retinopathy or 
other pre-existing ophthalmic disease responsible for decreased vision 
were excluded, post operative visual acuity of 20/40 or better was 
obtained in 93% of diabetic eyes and 96% of non-diabetic eyes. 
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SUMMARY AND CONCLUSION 
Hundred diabetic patients who underwent cataract surgery were 
evaluated.  Diabetes leads to an increase in age related cataract 
development and more so in females.  The typical snowflake diabetic 
cataract has become a rare entity and the cortical variety is the 
commonest.  Hypertension and IHD were found to be more associated 
with diabetes. 
A thorough ocular evaluation before cataract surgery is 
mandatory.  Pre operative preparation especially mydriasis is a crucial 
factor in determining the outcome of surgery.  LA with peribulbar / retro 
bulbar is the anaesthesia of choice in diabetic patients for cataract 
surgery.  
In the study, intra operative miosis 12% was most common intra 
operative complication followed by posterior capsular rent 6% and 
vitreous loss in 8%.  This is more compared to non diabetics.  Bleeding 
in one of the complications occurring more in diabetics.  Post 
operatively corneal edema (19%) was more common than others.  Post 
operative iritis occurred in 10%.   
Macular edema was a most common long term complication(4%) 
and recurrent uveitis in (2%) retinopathy progression was found only 
2% of the patients.  BCVA of 6/12 or better was achieved in 68% of the 
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cases.  17% had BCVA of 6/24 – 6/18.  15% had BCVA < 6/36.  BCVA 
of < 6/12 was due to the complications of surgery due to diabetes and 
other co-existing ocular co morbidity.  
Best result of cataract surgery in diabetics was achieved by 
adapting the following measures. 
Pre operative  
¾ Decision regarding the timing the cataract surgery in patients with 
diabetic retinopathy. 
¾ Meticulous patient work up regarding other systemic complications 
and glycemic control. 
¾ A detailed ocular evaluation with special regard to lid and adnexal 
infections, tear film abnormalities, keratoepitheliopathy, endothelial 
integrity, motility disorders, optic nerve assessment, retinopathy 
status and other ocular diseases.  Routine gonioscopy and evaluation 
of the morphology of the lens was done.   
¾ Care was taken regarding adequate pre operative mydriasis and 
maintain with NSAIDS . 
Intro operative 
¾ Local anaesthesia is the anaesthesia of choice in diabetics. 
¾ Patients were draped with lashes out of the operative field. 
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¾ Intra cameral preservative free 1:10000 epinephrine at the start of 
surgery was used.  High molecular weight visco elastic substance 
(Healon) was used only in a very few patients due to financial 
constraints.  Heparanised infusion concentration 10 IU/ml was used 
in the irrigation solution and was found to be beneficial. 
¾ SICS was associated with better post operative visual acuity and less 
post-operative inflammation.  Minimal invasion and surgical skill is 
an essential.  A large anterior capsulotomy with 6.5mm IOL was 
used.  Silicon IOL should be avoided in patients with advanced 
diabetic retinopathy.   
¾ Post operative topical antibiotic steroid  was used for a period of 6 
weeks and long term follow up was done regarding retinopathy 
status and complications of surgery    
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PROFORMA 
 
Name  :                                                          Age/sex:                  IP No : 
Occupation :                                                                                          OP No :  
Address : 
 DIAGNOSIS :                                                                                          DOA : 
                                                                                                       DOS : 
                                                                                                       DOD :   
HISTORY :                                                                                                                                                     
Duration of D.M. 
Type 
Mode of  treatment 
Associated systemic illness  :HT/IHD/Hypercholestrlemia 
Asthma,Steroid intake,prior surgery,  
Other history 
GENERAL EXAMINATION & INVESTIGATIONS:  
CVS :     FBS : 
RS :     PPBS : 
CNS :     ECG :       
PR :     BP :      Glycosalated  Hb :         
OCULAR EXAMINATION :   Oblique  and  Slit lamp    
                                                             OD                                       OS 
• Face 
• Lids/Brow 
• Conjunctiva 
• Cornea 
• AC 
• Pupil 
• Iris 
• Lens 
• V/A 
• RR 
• IOT 
• Duct 
• Fundus 
    
Pre-op control of Blood sugar: 
1. OHA&Diet 
2. Insulin 
3. OHA&Insulin 
PCIOL:                                                       ACIOL: 
Surgery: ECCE/SICS/otherprocedures 
PER-OP COMPLICATIONS   POST-OP COMPLICATONS     
• Anesthetic                                                       Corneal odema  
• AC Haeomorrhage                                          Raised IOP    
• AC Collapse     Periocularbruising/ odema  
• IRIS-tear/dialysis/prolapse   External eye infection  
• Choroidal Haemorrhage   Wound leak   
• PC rupture                                                      Vitreous in the wound    
• Vitreous Disturbance                                      Hyphaema  
• Descemet`s stripping                                      Uveitis 
• Retained Cortex                                              Iris abnormality 
• Loss of  nuclear fragments into vitreous Retained cortex   
• Abnormality in wound closure  Pupil block 
                                                                                    IOL dislocation 
                                                                                    Endophthalmitis  
LONG TERM COMPLICATIONS: 
• CMO 
• Uveitis-Refractory 
• Retinopathy Status 
POST-OP DIABETES MANAGEMENT: 
• Fundus- 
• Retinoscopy- 
• Best corrected V/A- 
Note/Other details- 
 
ANATOMY OF THE CRYSTALLINE LENS 
WEDGE SHAPED OPACITIES AND VACUOLES  
IN CORTICAL CATARACT 
SNOW FLAKE CATARACT 
MORGAGNIAN CATARACT 
ANTERIOR AND POSTERIOR SUBCAPSULAR OPACIFICATION 
PREOPERATIVE PREPARATION 
 
EXUDATIVE MEMBRANE IN A CASE OF RECURRENT UVEITIS 
RECURRENT UVEITIS WITH ACIOL IMPLANTATION 
SCH AND CHEMOSIS THAT OCCURED   
DURING ANAESTHESIA  
POSTOPERATIVE HYPHAEMA 
CORNEAL EDEMA WITH DESCEMETS FOLDS 
PUPILLARY BLOCK WITH CORNEAL EDEMA 
 
RETAINED CORTICAL MATERIAL  
YAG  CAPSULOTOMY DONE IN A PATIENT WITH PCO 
 
40-50 years51-60 years61-70 years> 71 years
18% 47% 29% 6%
Male Female
33% 67%
Immature CMature CorHypermatu Nuclear PolychromaBread CrumSnowflake 
54% 23% 3% 16% 1% 2% 1%
IntraopeativPCR ZonulodialyVitreous LoPigment re Iris Bleed SCH Iris Tear
12% 6% 2% 8% 3% 1% 1% 2%
Corneal EdIritis RLM RIOP Iris ProlapsHyphaema Wound lea IOL Malpos
19% 10% 3% 4% 2% 1% 1% 1%
CMO Recurrent UProlonged Cyst PCO Evisceration
4% 2% 2% 1% 2% 1%
<6/60 6/60 - 6/36 6/24 - 6/18 6/12 - 6/6 No PL / PR 
10% 4% 17% 68% 1%
<6/60 6/60 - 6/18 6/12 - 6/6
40-50 years 1% 1% 16%
51-60 years 4% 6% 32%
61-70 years 4% 11% 17%
> 71 years 0% 4% 3%
RLM PPCO Calcified anterior capsule
1% 1% 1%
Vitreous in Periorbital ReactivatioSuprachoroidal haemorrhage
1% 1% 1% 1%
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CATARACT MORPHOLOGY
POST-OPERATIVE COMPLICATIONS 
(48 hrs)
19%
10%
3%
4%
2%
1%
1%
1%
1%
1%
1%
1%
0% 5% 10% 15% 20%
Corneal Edema
Iritis
RLM
RIOP
Iris Prolapse
Hyphaema
Wound leak
IOL Malposition
Vitreous in wound
Periorbital Bruise
Reactivation
Choroiditis
Suprachoroidal
haemorrhage
10%
4%
17%
68%
1%
0%
10%
20%
30%
40%
50%
60%
70%
<6/60 6/60 - 6/36 6/24 - 6/18 6/12 - 6/6 No PL / PR 
BCVA - 6 WEEKS
1% 1%
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BCVA WITH AGE
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1 CHINNAPONNU 70 2 6/12/2005 40225 N 5-M 4-E A HT O / D 6 2 NIL PCR / VD / CO / RIOP CMO 2./60 3./60 NIL NIL
2 KESAVAN 69 1 15/10/5 41729 C 5-I 4-S PC NIL O / I 4 2 NIL NIL NIL NIL 6./18 6/9P NIL NIL
3 SEENIAMMAL 60 2 18/9/5 41833 C 5-I 3-S PC NIL O/I 4 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
4 MAHESWARI 50 2 18/9/5 41870 C 3-PS 4-IM 4-S PC AS I 3 2 AL NIL NIL NIL 6./9 6./6 NIL NIL
5 RAGHUPATHY 75 1 20/9/5 42586 C 3-PS 4-M 4-S PC HT O / I 8 2 NIL NIL NIL NIL 6./24 6/9P NIL BDR & HT 
GR-1 / 
SAME
6 SULEKA BEE 53 2 25/9/5 04421 P-PO 
LU
5 - PSC 3-S PC HT / IHD 
/ HYP/OBE
O / I 8 2 NIL PR NIL NIL 6./24 6./9 YES NIL
7 VALLIAMMAL 60 2 2/10/2005 04428 C 3-IM 4-PS 3-S PC NIL O /I 2 2 NIL IOM IRITIS NIL 6./18 6/6P NIL NIL
8 KASTHURI 57 2 17/9/4 45228 C 4-IM 3-PS 4-S PC HT O /I 7 2 NIL NIL NIL NIL 6./12 6./9 NIL BDR SAME
9 BEGUM BEE 50 2 3/10/2005 45247 C 3-PS 4-IM 4-S PC NIL I 3 2 NIL NIL NIL NIL 6./9 6./6 NIL NIL
10 KASTHURI 52 2 6/10/2005 46410 C 5-IM 3-S PC OBESITY O/I 3 2 NIL NIL RLM NIL 6./60 6/9P NIL NIL
11 KALIAMMAL 75 2 3/10/2005 46407 N 5-N 3-E / PI A HT I 2 2 NIL NIL CO / RLM NIL 10D - 
3/60
6./36 NIL NIL
12 VEDHA MANICKAM 66 1 15/10/5 46417 C 5-IM 3-S PC NIL O/I 8 2 NIL NIL HY NIL HM 5./60 NIL NIL
13 KANNIAPPAN 61 1 12/10/2005 46412 C 3-A 4-PMG 4-S A NIL O/I 6 2 PM.GL CC/PCR/V
D/ SY
IRITIS CMO 10D-6/36 4./60 NIL NIL
14 INDRANI 40 2 25/10/5 47403 SF 5 IM 3 
PTERYGI
UM
3-S PT 
EX
PC NIL I 3 MOD
Y
PTERYGIU
M
NIL NIL NIL 6./24 6/6P NIL NIL
15 RAJESHWARI 58 2 27/9/05 44083 C 3-PLG/ 4-
PS
3-S/EV PC HT/ I 8 2 HT/PLG IOM SUPRA 
CHOROIDA
L HE
EVISCERATI
ON
NIL NIL NIL NIL
16 ROSE 55 1 13/6/5 22847 C 5-M 4-S PC NIL I 5 2 CFHOROIDI
TIS
NIL CO/UVEITIS UVEITIS CFCF HM NIL NIL
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17 KRISHNAN 60 1 13/6/05 25400 C 5-IM 5-S PC HT O/I 4 2 NIL IP/IRIS 
TEAR/ 
IOM
IP NIL 6./36 6./9 YES NIL
18 RAJAMANI 60 2 21/5/5 48421 C 5-IM 3-S PC AS O/I 1 2 NIL NIL NIL NIL 6./9 6./6 NIL NIL
19 LAKSHMIAMMAL 65 2 15/6/5 48413 C 4-M 3-A 4-S A NIL O/I 7 2 NIL NIL CO NIL 2./60 
WITH 
10D
6./18 NIL NIL
20 RUKHMANI 50 2 7/12/2005 53361 N 4-N 3 A 4-S PC NIL I 1 2 NIL PRIMARY 
PCO
NIL NIL 6./18 6./12 YES NIL
21 MUTHU 65 1 5/12/2005 47443 C 5-
POAG/IM
5-T/E PC NIL O/I 7 2 POAG NIL NIL NIL 6./24 6./18 YES NIL
22 LAKSHMI 50 2 7/12/2005 53391 C 3-IM 4-M 4-S PC NIL O/D 3 2 NIL NIL NIL NIL 6./36 6./12 NIL NIL
23 ABOORVAM 60 2 15/6/5 52906 C 5-IM 4-S PC NIL O/I 2 2 NIL NIL NIL NIL 6./36 6./12 YES  MOD 
NPDR 
SAME
24 MADHEENA BEGUM 50 2 5/12/2005 53856 C 5IM 3-S PC IHD I 4 2 NIL PCR / 
VD/IOM
NIL NIL 6./60 6./9P NIL NIL
25 KANIAMMAL 65 2 15/6/5 54585 C 3-M 4-IM 3-S PC NIL O/I 9 2 NIL RLM/IOM CO NIL HM FC NIL NIL
26 SUBRAMANI 76 1 21/9/5 39971 C 3-IM 4-PS 3-S PC NIL I 4 2 NIL Nil IRITIS NIL 6./24 6./12 NIL NIL
27 SULOCHANA 64 2 21/9/5 19361 N 5 N 4-S/3-S PC IHD O/I 18 2 NIL NIL NIL NIL 6./36 6./24 YES MILDprgnM
OD NPDR
28 ADHILAKSHMI 50 2 23/3/5 11819 C 3-M,4-IM 5 S PC NIL O/I 1 2 NIL NIL NIL NIL 6./12 6./6 YES NIL
29 REGINAMARY 60 2 21/9/5 20253 C 3-PS 4-IM 4-S PC NIL O/I 1 2 NIL NIL NIL NIL 6./18 6./9 NIL NIL
30 SUNDARI 65 2 4/7/2004 20798 C 3-PS 4-IM 4-S PC NIL O/I 2 2 NIL NIL NIL NIL 6./18 6./9 NIL NIL
31 THAMYLNAYAGI 70 2 24/6/4 17472 C 3-PS 4-IM 4-S PC HT O/I 8 2 HT-
RPTY/ARM
D
NIL NIL NIL 6./36 6./18 NIL MILDNPDR 
SAME
32 PAPATHY 68 2 13/6/4 14181 P-BC 5-IM 4-
PSCC
4-S PC NIL O/I 6 2 OLD 
UVEITIS
IRIS TEAR IRITIS NIL 6./24 6./18 NIL NIL
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33 INDRANI 50 2 8/6/2004 18095 c 5-IM 3-S PC NIL O/I 8 2 NIL ZD/VD/IO
M
VITREOUS 
IN WOUND
CMO 5./60 3./60 NIL BDR SAME
34 KHADER 65 1 2/6/2004 17664 C 5-IM 3-S PC NIL O/I 8 2 NIL Nil /IP NIL NIL 6./36 6./18P NIL BDR SAME
35 LAKSHMI 60 2 26//5/4 18655 C 5-IM 3-S PC NIL O/I 2 2 NIL NIL NIL NIL 6./24 6./9 NIL NIL
36 DILLIBABU 69 1 13/5/4 15047 C 5-IM 4-S PC IHD O/I 3 2 NIL NIL NIL NIL 6./36 6./12 NIL NIL
37 MANNAN 65 1 5/5/2004 13726 C 3-N/4-M 3-S PC NIL O-D 5 2 NIL NIL NIL NIL 6./36 6./12 NIL NIL
38 RAJAMMAL 55 2 3/5/2004 16013 C 3-PS/4-M 4-S PC HT O/D 7 2 NIL NIL CO NIL 6./24 6./9 NIL MILDprgnM
OD NPDR
39 RANI 60 2 7/12/2005 54588 C 3-M 4-PS 3-S PC HT O/D 5 2 NIL NIL CO NIL 6./60 6./18 NIL NIL
40 BAREETH 70 1 5/1/2005 3972 C 5-M 4-S PC HT O/I 10 2 NIL NIL NIL NIL 6./24 6./9 YES NIL
41 VELAYUTHAM 55 1 5/1/2005 45350 C 3-M 4-IM 3- S PC NIL O/I 2 2 NIL PR NIL NIL 6./18 6./9 NIL NIL
42 NAGAMMAL 60 2 5/1/2005 1103 C 5-IM 4-S PC OBE O/I 6 2 NIL NIL NIL NIL 6./18 6./12 YES NIL
43 JAGEERABEE 60 2 5/1/2005 4115 N 5-N 3 S PC NIL O/I 2 2 NIL NIL NIL NIL 6./24 6./6 NIL NIL
44 VENKATAMMA 65 2 11/2/2005 5120 C 3-PS 4-M 4-E PC NIL O/I 5 2 NIL ZD/VD CO NIL 6./24 6./9 NIL NIL
45 JEYA 69 2 4/2/2005 2280 C 5-IM 3-S PC NIL O/I 5 2 NIL NIL IOL RP 
DONE
NIL 6./60 6./12 YES NIL
46 VASUGI 58 2 4/2/2005 4731 N 3-N4-PS 3-E PC NIL O/I 2 2 NIL NIL NIL NIL 6./36 6./6 NIL NIL
47 MANICKAM 79 1 7/1/2005 730 N 5-N 4-E AC HT/AS O/D 8 2 NIL PCR/VD/
IOM
CO RU / PCO 6./60 1/60 YES NIL
48 CHINNAPONNU 40 2 20/12/4 41218 C 5-IM 4-S PC NIL I 10 1 NIL NIL NIL NIL 6./24 6./6 YES NIL
49 MADHAVAN 61 1 16/12/4 43082 C 5-IM 3-S PC HT O/I 4 2 NIL IOM NIL NIL 6./9 6./6 NIL NIL
50 KUPPUSAMY 60 1 14/12/5 43109 C 5-IM 4-S PC NIL O/I 3 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
51 KATHIRVEL 55 1 11/12/2004 41342 C 3-HM 4-IM 3-E PC NIL O/I 4 2 IRIS 
COLOBOMA
NIL NIL NIL 2./60 4./60 NIL NIL
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52 SABHAPATHY 70 1 16/4/4 11394 N 5-N 4-E PC HT/IHD O/I 8 2 NIL NIL CO R IOP 5./60 6./36 NIL NIL
53 RAMAIAH 65 1 17/9/4 30851 C 3-M 4-PS 3-S PC NIL O/I 4 2 MACULAR 
HOLE
NIL NIL NIL 2./60 4./60 NIL NIL
54 MAZUK BEGUM 65 2 22/9/4 30934 C 3-M 4-IM 3-T/E PC NIL O/I 7 2 POAG NIL NIL NIL 6./36 6./18 NIL NIL
55 MUTHULAKSHMI 69 2 15/10/4 34824 N 5-N 3-S PC IHD O/I 6 2 NIL NIL NIL NIL 6./24 6./9 YES NIL
56 NAGAMMAL 60 2 15/10/4 34805 C 5-IM 3-E PC NIL O/I 4 2 NIL PCR/
VD
CO RU 6./36 6./24 NIL NIL
57 CHANDRAMMA 75 2 27/11/4 38457 C 3-M 4-
PMG
4-E PC NIL O/I 7 2 PMG NIL NIL NIL 6./36 6./12P NIL NIL
58 KASTHURI 55 2 25/11/4 38867 C 4-IM 
3-AC G
3-E/T PC NIL O/I 3 2 ACG NIL NIL NIL 3./60 6./60 NIL NIL
59 RADHABAI 52 2 6/12/2004 41725 C 3-IM 4 PS 3-E PC NIL O/I 1 2 NIL NIL NIL NIL 6./36 6./12 NIL NIL
60 CECILY 62 2 7/12/2004 42026 C 3-M 4-IM 3-E PC NIL O/I 3 2 NIL IOM IRITIS NIL 6./36 6./12 NIL NIL
61 FATHIMA BEE 54 2 3/12/2004 41469 C 5-IM 3-E PC NIL O/I 2 2 NIL NIL NIL NIL 6./24 6./6 NIL NIL
62 RAJESHWARI 60 2 3/12/2004 40785 C 3-IM 4 M 4-E PC NIL O/I 5 2 NIL NIL NIL NIL 6./36 6./9 NIL NIL
63 CHINNAPPAN 75 1 25/11/4 38939 N 5-N 4-E PC NIL O/I 4 2 NIL NIL CO CO 5./60 6./24 NIL NIL
64 VEERAMUTHU 42 1 24/11/4 38995 C 4-M 3IM 3-S PC NIL O/I 3 2 NIL NIL NIL NIL 6./24 6./9 NIL NIL
65 VALLIAMMAL 60 2 10/11/2004 34850 C 3-M 4 PS 3-E PC NIL O/I 6 2 NIL NIL NIL NIL 6./18 6./9 NIL NIL
66 PUSPHA 59 2 9/11/2004 38130 C 5-IM 3-E PC NIL O/I 4 2 NIL NIL CO/IRITIS RIOP 6./36 6./24 NIL NIL
67 MANGALASUNDARI 63 2 10/11/2004 37640 C 5-IM 3-S PC NIL O/I 5 2 NIL NIL NIL NIL 6./12 6./6 YES NIL
68 LAKSHMI 55 2 3/11/2004 37445 N 3-N 4-HM 4-E PC NIL O/I 8 2 NIL NIL NIL NIL 6./36 6./24 YES NIL
69 RAMALINGAM 60 1 2/11/2004 37145 C 5-IM 4-E A NIL O/I 6 2 NIL PCR/ VD CO CMO 6./60 5./60 NIL NIL
70 EILAMANTHAI 70 1 29/10/4 36389 C 5-IM 3-S PC NIL O/I 4 2 NIL NIL NIL NIL 6./18 6./9 YES NIL
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71 MUNYAMMAL 59 2 4/11/2004 327218 C 5-IM 3-S PC NIL O/I 3 2 NIL IOM NIL NIL 6./36 6./12 NIL NIL
72 MOHANA 55 2 29/10/4 36380 C 5-IM 3-S PC NIL O/I 1 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
73 ZULAKA BEE 40 2 14/10/4 34678 C 5-IM 3-E PC NIL O/I 2 2 NIL NIL NIL NIL 6./24 6./9 NIL NIL
74 MANONMANI 60 2 12/10/2004 34373 C 5-IM 3-E PC NIL O/I 3 2 NIL NIL NIL NIL 6./24 6./9 NIL NIL
75 VALLI 55 2 8/10/2004 33867 C 5-HM 4=S PC NIL O/I 5 2 NIL NIL CO/RIOP NIL 6./36 6./12 NIL NIL
76 SUNAITA BEE 65 2 15/10/4 33845 C 5-IM 3S PC NIL O/I 3 2 NIL IOM, PR NIL NIL 6./24 6./9 NIL NIL
77 HANIFA 60 1 7/10/2004 33697 N 3-PS 4 N 4-E PC NIL O/I 4 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
78 NAGARAJ 46 1 8/10/2004 32127 C 3-IM 4-PS 3-E PC NIL O/I 3 2 NIL NIL NIL NIL 6./18 6./9 NIL NIL
79 IMMANUEL 68 1 30/9/4 32831 C 5-IM 4-E PC NIL O/I 2 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
80 KANNIGA 50 2 30/9/4 32589 C 3-M 4 PS 3-E PC NIL O/I 1 2 NIL NIL RLM / IRITIS NIL 6./18 6./12 NIL NIL
81 KUPPAMMAL 65 2 22/9/4 3122 C 3-IM 4-M 4-S PC NIL O/I 2 2 ARMD NIL NIL NIL 6./60 6./36 NIL NIL
82 PREMILA 45 2 22/9/4 31661 C 3-IM 4-PS 3-S PC NIL I 20 1 NIL NIL NIL NIL 6./24 6./9 NIL MOD NPDR 
SAME
83 AMARALLI 52 1 22/9/4 31739 C 5-IM 3-S PC NIL O/I 4 2 NIL NIL IRITIS NIL 6./18 6./12 NIL NIL
84 RANGANATHAN 65 1 17/9/4 30931 C 3-IM 4-PS 3-S PC NIL O/I 2 2 NIL NIL NIL NIL 6./18 6./9 NIL NIL
85 SAMPATH 61 1 16/9/4 31015 N 5-N 3-E PC HT O/I 3 2 COR-NEAL 
OPACITY
NIL CO NIL 6./36 6./18 NIL NIL
86 NEELA 48 2 15/9/4 30852 C 5-IM 3-E PC NIL O/I 2 2 NIL NIL NIL CYST 6./12 6./9 NIL NIL
87 KUPPAMMAL 70 2 2/9/2004 28487 C 5-IM 3-E PC NIL O/I 7 2 NIL IRIS 
BLEED
CO/RIOP NIL 6./36 6./24 NIL NIL
88 JABURALA KHAN 64 1 30/8/4 28286 C 5-I 4-S PC NIL O/I 3 2 NIL NIL NIL NIL 6./9 6./6 NIL NIL
89 JAGADHEESAN 55 1 30/8/5 28325 C 3-PS 
4-IM
4-S PC NIL O/I 2 2 NIL NIL WOUND 
LEAK
NIL 5./60 6./24 NIL NIL
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90 SAROJA 60 2 30/8/4 27763 C 5-IM 4-S PC NIL O/I 3 2 NIL NIL NIL NIL 6./12 6./9 NIL NIL
91 BEENA 50 2 29/4/4 13614 N 3-IM 4-N 4-E PC NIL O/I 2 2 NIL IOM CO PCO 6./60 6./12 NIL NIL
92 SHANTHA 65 2 28/4//4 12836 N 3-N 4-PS 3-E PC NIL O/I 3 2 NIL NIL NIL NIL 6./18 6./9 NIL NIL
93 THANGAM 55 2 19/4/4 12213 C 3-PS 4-IM 4-S PC NIL O/I 2 2 NIL NIL NIL NIL 6./12 6./9 NIL NIL
94 PONNUSAMY 50 1 6/4/2004 10556 C 3-IM 4-M 4-E PC NIL O/I 2 2 NIL NIL IP/IRITIS NIL 6./60 6./24 NIL NIL
95 SULEKA BEE 70 2 7/7/2004 11094 N 5-N 3-E PC NIL O/I 4 2 NIL NIL NIL NIL 6./24 6./12 NIL NIL
96 PONNI 55 2 6/4/2004 31024 C 5-IM 3-S PC NIL O/I 4 2 NIL NIL PERIORBIT
AL BRUISE
NIL 6./18 6./12 NIL BDR SAME
97 FATIMA 60 2 16/9/04 32784 C 5-IM 4-E PC NIL O/I 3 2 NIL Nil CO NIL 5./60 6./24 NIL NIL
98 PENCILLAMMA 52 2 4/4/2004 31274 C 5-IM 3-S PC HT O/I 2 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
99 RATINAMMA 57 2 28/4/4 12876 C 3-M 4IM 3-E PC NIL O/I 5 2 NIL SCH-
ANES
NIL NIL 6./18 6./9 NIL NIL
100 RASU 49 1 17/9/4 31298 C 5IM 4-S PC NIL O/I 3 2 NIL NIL NIL NIL 6./12 6./6 NIL NIL
